Infect Chemother.  2008 Dec;40(6):337-340. 10.3947/ic.2008.40.6.337.

A Case of Diabetic Foot Infection due to Mycobacterium mageritense

• Kim CJ
• Kim NH
• Kim M
• Kim KH
• Jeon JH
• Park MS
• Park KU
• Park WB
• Park SW
• Kim HB
• Kim NJ
• Oh MD
• Choe KW

• KMID: 1782302
• DOI: http://doi.org/10.3947/ic.2008.40.6.337

Abstract

Diabetic foot infection is one of the important complications in patients with advanced diabetes mellitus. Limb threatening infections such as osteomyelitis, abscess, and necrotizing fasciitis are frequently accompanied by the disease. Non-tuberculous mycobacterium (NTM) is a rare causative organism of diabetic foot infection. Thus, if one is not suspicious or meticulous, infection due to NTM will be easily overlooked and this will result in delayed diagnose and treat. Therefore, it is necessary to consider NTM as the causative organism if the wound does not respond to the conventional antibiotic treatment and the culture from the adequately obtained specimen reveals atypical acid-fast bacilli. We present a case of diabetic foot infection with osteomyelitis and abscess due to Mycobacterium mageritense, one of the rapid growing mycobacteria, that was successfully treated with surgical debridement and appropriate antibiotic treatment.

Keyword

Mycobacterium mageritense; Diabetic foot; Osteomyelitis

MeSH Terms

Abscess
Debridement
Diabetes Mellitus
Diabetic Foot
Extremities
Fasciitis, Necrotizing
Humans
Mycobacterium
Osteomyelitis

Figure

• 

  Figure 1 (A) 3.5 cm-sized large ulcerative lesion was found on the lateral aspect of left malleolus. (B) The diffuse abnormal signal intensity of the bone marrow with intramedullary rim enhancement, suggestive of osteomyelitis with abscess in left malleolus, was shown on the coronal view of T1-weighted magnetic resonance image.

• 

  Figure 2 Eugonic and smooth colonies were visible on blood agar plate after 3-day incubation at 37℃.

Reference

1. Abbott CA, Carrington AL, Ashe H, Bath S, Every LC, Griffiths J, Hann AW, Hussein A, Jackson N, Johnson KE, Ryder CH, Torkington R, Van Ross ER, Whalley AM, Widdows P, Williamson S, Boulton AJ. North-West Diabetes Foot Care Study. The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med. 2002. 19:377–384.

2. Kim JM, Kim DY, Woo JT, Kim SW, Yang IM, Kim JW, Kim YS, Kim KW, Coi YK. A clinical study on the diabetic foot lesions. J Korean Diabetes Assoc. 1993. 17:387–394.

3. Lipsky BA, Berendt AR, Deery HG, Embil JM, Joseph WS, Karchmer AW, LeFrock JL, Lew DP, Mader JT, Norden C, Tan JS. Infectious Diseases Society of America. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2004. 39:885–910.

4. Park JY, Lee SJ, Ahn YS, Lee JH, Lee IS, Kim JY, Cheon SJ, Lee SH, Kwak IS. A case of sporotrichoid cutaneuos infection caused by Mycobacterium marinum. Infect Chemother. 2006. 38:169–173.

5. Wallace RJ Jr, Swenson JM, Silcox VA, Good RC, Tschen JA, Stone MS. Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis. 1983. 5:657–679.

6. Kim YS, Hong IC, Kim CK, Kim SW, Kim S, Peck KR, Kim BJ, Kook YH, Song JH. A case of skin and soft tissue infection caused by Mycobacterium abscessus. Korean J Infect Dis. 2000. 32:64–68.

7. Park CM, Heo SR, Park KU, Song J, Lee JH, Lee CT, Kim EC. Isolation of nontuberculous mycobacteria using polymerase chain reaction-restriction fragment length polymorphism. Korean J Lab Med. 2006. 26:161–167.

8. O'Brien DP, Currie BJ, Krause VL. Nontuberculous mycobacterial disease in northern Australia: a case series and review of the literature. Clin Infect Dis. 2000. 31:958–967.

9. Henry MT, Inamdar L, O'Riordain D, Schweiger M, Watson JP. Nontuberculous mycobacteria in non-HIV patients: epidemiology, treatment and response. Eur Respir J. 2004. 23:741–746.

10. Esteban J, Fernndez Roblas R, Garca Ca JI, Zamora N, Ortiz A. Clinical significance and epidemiology of non-pigmented rapidly growing mycobacteria in a university hospital. J Infect. 2007. 54:135–145.

11. Wallace RJ Jr, Brown-Elliott BA, Hall L, Roberts G, Wilson RW, Mann LB, Crist CJ, Chiu SH, Dunlap R, Garcia MJ, Bagwell JT, Jost KC Jr. Clinical and laboratory features of Mycobacterium mageritense. J Clin Microbiol. 2002. 40:2930–2935.

12. Park YM, Kang H, Cho SH, Cho BK, Kim BJ, Kook YH, Park EM. A case of scrofuloderma caused by Mycobacterium fortuitum. Korean J Infect Dis. 1999. 31:171–175.

13. Jeon SJ, Suh KS, Kim ST, Yoo GS, Park ID, Chang MW. A case of cutaneous infection due to Mycobacterium fortultum. Korean J Dermatol. 1991. 29:640–646.

14. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ Jr, Winthrop K. ATS Mycobacterial Diseases Subcommittee. American Thoracic Society. Infectious Disease Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007. 175:367–416.

15. Nash KA, Andini N, Zhang Y, Brown-Elliott BA, Wallace RJ Jr. Intrinsic macrolide resistance in rapidly growing mycobacteria. Antimicrob Agents Chemother. 2006. 50:3476–3478.